Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000899243-19-026127

EVP, Chief Financial Officer sold 13,834 shares at an average $120.45 ($1,666,271)

  • EVP, Chief Financial Officer acquired 11,231 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Burke William P. Mr. · EVP, Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-10-25 Exercise or conversion : show line 1 in the form +11,231 $34.21 $384,213 24,245 D
2019-10-25 Sale : show line 2 in the form −6,905 $119.87 $827,702 17,340 D
2019-10-25 Sale : show line 3 in the form −4,326 $120.65 $521,932 13,014 D
2019-10-28 Sale : show line 4 in the form −1,155 $120.33 $138,981 11,859 D
2019-10-29 Sale : show line 5 in the form −1,448 $122.69 $177,655 10,411 D
Open-market sales · 13,834 sh · avg $120.45 · $1,666,271

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-10-25 Exercise or conversion : show line 6 in the form Non-qualified Stock Option (Right to Buy) −11,231 11,232 D
Loading xslF345X03/doc4.xml…